Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETOILES: Long-term Safety of Tobramycin Inhalation Powder in Cystic Fibrosis
NCT01519661Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of tobramycin in cystic fibrosis (CF), sponsored by Novartis. Started Jan 2012; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01519661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01519661.